
Joseph R. Kosack
Examiner (ID: 57, Phone: (571)272-5575 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 3991, 1626 |
| Total Applications | 1824 |
| Issued Applications | 1288 |
| Pending Applications | 93 |
| Abandoned Applications | 467 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19411700
[patent_doc_number] => 12077505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Preparation of sulfonamide herbicide process intermediates
[patent_app_type] => utility
[patent_app_number] => 17/296695
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3838
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296695
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296695 | Preparation of sulfonamide herbicide process intermediates | Dec 19, 2019 | Issued |
Array
(
[id] => 16206408
[patent_doc_number] => 20200239398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => METHYLENE-CYCLOALKYLACETATE DERIVATIVES AND THEIR USE IN TREATMENT OF NEUROTROPIC CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/714746
[patent_app_country] => US
[patent_app_date] => 2019-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16714746
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/714746 | METHYLENE-CYCLOALKYLACETATE DERIVATIVES AND THEIR USE IN TREATMENT OF NEUROTROPIC CONDITIONS | Dec 14, 2019 | Abandoned |
Array
(
[id] => 16704317
[patent_doc_number] => 10954237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => JAK inhibitors containing a 4-membered heterocyclic amide
[patent_app_type] => utility
[patent_app_number] => 16/701426
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18976
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16701426
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/701426 | JAK inhibitors containing a 4-membered heterocyclic amide | Dec 2, 2019 | Issued |
Array
(
[id] => 17727727
[patent_doc_number] => 11384102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Lithium alkyl aluminates as alkyl transfer reagents
[patent_app_type] => utility
[patent_app_number] => 17/312761
[patent_app_country] => US
[patent_app_date] => 2019-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22960
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 296
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312761
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/312761 | Lithium alkyl aluminates as alkyl transfer reagents | Nov 27, 2019 | Issued |
Array
(
[id] => 16635245
[patent_doc_number] => 10913740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-09
[patent_title] => JAK kinase inhibitor compounds for treatment of respiratory disease
[patent_app_type] => utility
[patent_app_number] => 16/689706
[patent_app_country] => US
[patent_app_date] => 2019-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 22759
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16689706
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/689706 | JAK kinase inhibitor compounds for treatment of respiratory disease | Nov 19, 2019 | Issued |
Array
(
[id] => 17356755
[patent_doc_number] => 20220017551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => SELECTIVE DETECTION OF BED BUGS
[patent_app_type] => utility
[patent_app_number] => 17/295316
[patent_app_country] => US
[patent_app_date] => 2019-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295316
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/295316 | SELECTIVE DETECTION OF BED BUGS | Nov 19, 2019 | Abandoned |
Array
(
[id] => 15927753
[patent_doc_number] => 20200155510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => TREATMENT OF AUTOIMMUNE DISORDERS, SUCH AS RELAPSING REMITTING MULTIPLE SCLEROSIS AND CLINICALLY ISOLATED SYNDROME WITH BIOTIN COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/681285
[patent_app_country] => US
[patent_app_date] => 2019-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16681285
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/681285 | TREATMENT OF AUTOIMMUNE DISORDERS, SUCH AS RELAPSING REMITTING MULTIPLE SCLEROSIS AND CLINICALLY ISOLATED SYNDROME WITH BIOTIN COMPOSITIONS | Nov 11, 2019 | Abandoned |
Array
(
[id] => 15895083
[patent_doc_number] => 20200147060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => COMPOSITIONS AND METHODS OF TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/668736
[patent_app_country] => US
[patent_app_date] => 2019-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16668736
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/668736 | COMPOSITIONS AND METHODS OF TREATING CANCER | Oct 29, 2019 | Abandoned |
Array
(
[id] => 15776541
[patent_doc_number] => 20200119288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => Metal-Assisted Delayed Fluorescent Emitters Employing Benzo-imidazo-phenanthridine and Analogues
[patent_app_type] => utility
[patent_app_number] => 16/668010
[patent_app_country] => US
[patent_app_date] => 2019-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16668010
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/668010 | Metal-assisted delayed fluorescent emitters employing benzo-imidazo-phenanthridine and analogues | Oct 29, 2019 | Issued |
Array
(
[id] => 15930959
[patent_doc_number] => 20200157113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/668743
[patent_app_country] => US
[patent_app_date] => 2019-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16668743
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/668743 | Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors | Oct 29, 2019 | Issued |
Array
(
[id] => 16743411
[patent_doc_number] => 10968386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Pentamethine cyanine dye and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 16/667864
[patent_app_country] => US
[patent_app_date] => 2019-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 6883
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 402
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16667864
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/667864 | Pentamethine cyanine dye and preparation method therefor | Oct 28, 2019 | Issued |
Array
(
[id] => 16999572
[patent_doc_number] => 11078366
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Bis-azo colorants for use as bluing agents
[patent_app_type] => utility
[patent_app_number] => 16/666868
[patent_app_country] => US
[patent_app_date] => 2019-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10684
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16666868
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/666868 | Bis-azo colorants for use as bluing agents | Oct 28, 2019 | Issued |
Array
(
[id] => 15598927
[patent_doc_number] => 20200075998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => CYCLIC COMPOUND, ANODE FOR LITHIUM ION SECONDARY BATTERY, AND LITHIUM ION SECONDARY BATTERY
[patent_app_type] => utility
[patent_app_number] => 16/664511
[patent_app_country] => US
[patent_app_date] => 2019-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16664511
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/664511 | CYCLIC COMPOUND, ANODE FOR LITHIUM ION SECONDARY BATTERY, AND LITHIUM ION SECONDARY BATTERY | Oct 24, 2019 | Abandoned |
Array
(
[id] => 16695458
[patent_doc_number] => 10946027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Tianeptine oxalate salts and polymorphs
[patent_app_type] => utility
[patent_app_number] => 16/597065
[patent_app_country] => US
[patent_app_date] => 2019-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8302
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16597065
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/597065 | Tianeptine oxalate salts and polymorphs | Oct 8, 2019 | Issued |
Array
(
[id] => 17228504
[patent_doc_number] => 20210355060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => PROTEIN KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/284432
[patent_app_country] => US
[patent_app_date] => 2019-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9236
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284432
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/284432 | PROTEIN KINASE INHIBITORS | Oct 8, 2019 | Abandoned |
Array
(
[id] => 15524655
[patent_doc_number] => 20200054633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => COMBINATION THERAPIES FOR TREATING INFLUENZA VIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/597326
[patent_app_country] => US
[patent_app_date] => 2019-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16597326
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/597326 | COMBINATION THERAPIES FOR TREATING INFLUENZA VIRUS INFECTION | Oct 8, 2019 | Abandoned |
Array
(
[id] => 15443499
[patent_doc_number] => 20200035933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => PHOTOELECTRIC CONVERSION ELEMENT, OPTICAL SENSOR, IMAGING ELEMENT, AND COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/593953
[patent_app_country] => US
[patent_app_date] => 2019-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16593953
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/593953 | Photoelectric conversion element, optical sensor, imaging element, and compound | Oct 3, 2019 | Issued |
Array
(
[id] => 17335995
[patent_doc_number] => 20220002326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => CATALYZED AND GREEN PROCESS OF MALATHION
[patent_app_type] => utility
[patent_app_number] => 17/280723
[patent_app_country] => US
[patent_app_date] => 2019-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280723
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/280723 | Catalyzed and green process of malathion | Sep 25, 2019 | Issued |
Array
(
[id] => 16878250
[patent_doc_number] => 11028386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Morpholino oligonucleotide manufacturing method
[patent_app_type] => utility
[patent_app_number] => 16/582392
[patent_app_country] => US
[patent_app_date] => 2019-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25423
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16582392
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/582392 | Morpholino oligonucleotide manufacturing method | Sep 24, 2019 | Issued |
Array
(
[id] => 16268648
[patent_doc_number] => 20200270135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => METHODS INVOLVING GRAPHENE AND FUNCTIONALIZED GRAPHENE
[patent_app_type] => utility
[patent_app_number] => 16/572386
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16572386
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/572386 | METHODS INVOLVING GRAPHENE AND FUNCTIONALIZED GRAPHENE | Sep 15, 2019 | Abandoned |